Recent Advances in The Treatment of Multiple Myeloma: Expert and Patient Perspectives

home / insights / recent-advances-in-the-treatment-of-multiple-myeloma-expert-and-patient-perspectives

Shaji Kumar, MD, and Krina Patel, MD, discuss key updates in the diagnosis and treatment of multiple myeloma. Jenny Ahlstrom, a patient, and Bonnie Falbo, a caregiver and patient advocate, share their personal journeys with multiple myeloma.

Induction Regimen Options for Patients with Transplant-Eligible Newly-Diagnosed Multiple Myeloma (NDMM)

EP. 1: Induction Regimen Options for Patients with Transplant-Eligible Newly-Diagnosed Multiple Myeloma (NDMM)

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
December 19th 2022

Krina Patel, MD, details the three- and four-drug regimen first-line treatment options for transplant-eligible newly-diagnosed multiple myeloma and how to make an appropriate treatment decision.

Introduction to Multiple Myeloma and Resources for Patient Education after Diagnosis

EP. 2: Introduction to Multiple Myeloma and Resources for Patient Education after Diagnosis

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
December 19th 2022

Shaji Kumar, MD, provides an overview of multiple myeloma, and Jenny Ahlstrom, a patient with multiple myeloma, shares the story of her diagnosis and the resources she used to educate herself.

The Role of Stem Cell Transplant in the NDMM Treatment Landscape

EP. 3: The Role of Stem Cell Transplant in the NDMM Treatment Landscape

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 3rd 2023

Dr Shaji Kumar reviews clinical trial data on the role of stem cell transplant as a treatment for newly-diagnosed multiple myeloma in tandem with a multi-agent combination therapy.

Optimal Treatment Selection for Patients with NDMM: Updates from IMS 2022

EP. 4: Optimal Treatment Selection for Patients with NDMM: Updates from IMS 2022

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 3rd 2023

Dr Krina Patel discusses updates in the treatment of newly-diagnosed from recent meetings how the appropriate treatments are selected in patients with newly-diagnosed multiple myeloma.

Available Induction Treatment Regimens for Patients with Transplant-Ineligible MM

EP. 5: Available Induction Treatment Regimens for Patients with Transplant-Ineligible MM

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 10th 2023

Shaji Kumar, MD, and Krina Patel, MD, discuss the treatment options for patients with newly-diagnosed multiple myeloma who are not eligible for stem cell transplant.

Key Considerations for Patients with Multiple Myeloma During the Treatment Journey

EP. 6: Key Considerations for Patients with Multiple Myeloma During the Treatment Journey

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 10th 2023

Jenny Ahlstrom, a patient with multiple myeloma, shares considerations for patients going through treatment, including toxicities, follow-up, and travel planning.

Treatment Options for MM at Early Relapse

EP. 7: Treatment Options for MM at Early Relapse

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 17th 2023

Krina Patel, MD, explains the treatment options for patients with early relapsed multiple myeloma.

Unmet Needs in the Treatment of NDMM and R/R MM and Clinical Pearls for Community Oncologists

EP. 8: Unmet Needs in the Treatment of NDMM and R/R MM and Clinical Pearls for Community Oncologists

Shaji Kumar, MD;Krina K. Patel, MD, MSc, University of Texas MD Anderson Cancer Center
January 17th 2023

The panel closes their discussion by highlighting unmet needs in the multiple myeloma treatment landscape and sharing advice for physicians and patients.